Advertisement
Advertisement
BBIO
BridgeBio Pharma, Inc. Common Stock
82.45
USDSponsored
+1.69
+2.09%
Jul 21, 16:00 UTC -4
Closed
After-Market
81.91
-0.55
-0.66%
BBIO Earnings Reports
Positive Surprise Ratio
BBIO beat 8 of 28 last estimates.
29%
Next Report
Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$222.67M
/-$0.60
Implied change from Q1 26 (Revenue/ EPS)
+14.47%
/-28.57%
Implied change from Q2 25 (Revenue/ EPS)
+101.39%
/-36.84%
BridgeBio Pharma, Inc. Common Stock earnings per share and revenue
On May 07, 2026, BBIO reported earnings of -0.84 USD per share (EPS) for Q1 26, missing the estimate of -0.69 USD, resulting in a -21.37% surprise. Revenue reached 194.51 million, compared to an expected 181.50 million, with a 7.17% difference. The market reacted with a -0.09% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of -0.60 USD, with revenue projected to reach 222.67 million USD, implying an decrease of -28.57% EPS, and increase of 14.47% in Revenue from the last quarter.
FAQ
What were BridgeBio Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, BridgeBio Pharma, Inc. Common Stock reported EPS of -$0.84, missing estimates by -21.37%, and revenue of $194.51M, 7.17% above expectations.
How did the market react to BridgeBio Pharma, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -0.09%, changed from $67.45 before the earnings release to $67.39 the day after.
When is BridgeBio Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 30, 2026.
What are the forecasts for BridgeBio Pharma, Inc. Common Stock's next earnings report?
Based on 13
analysts, BridgeBio Pharma, Inc. Common Stock is expected to report EPS of -$0.60 and revenue of $222.67M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement